Liver transplant rejection

1 trials MedDRA PT
1 Registered trials
0 Recruiting
1 Unique sponsors
1 Unique IMPs
1 Commercial trials
Drug classes (ATC)
— ATC code not specified 1
Mechanism of action (INN-stem analysis)
Unknown / small molecule 1 substance
Phase I (First in Human): 1

Filter these 1 trials by country, sponsor, date range and more.

Open in Search → Gap analysis →
Show: 1 trials

Phase I (First in Human)

1 trial
  • Quell Therapeutics Limited Commercial
    AUTOLOGOUS T REGULATORY CELLS EXPRESSING AN HLA-A2-SPECIFIC CHIMERIC ANTIGEN RECEPTOR
    2024-516193-30-01 2 countries 2023 n=14
    Ended
Sponsor activity
SponsorTypeTrialsPhasesRecruiting
Quell Therapeutics Limited Commercial 1 Phase I (First in Human) 0
New trials by year
2023
1
← All indication landscapes